Apr 17 |
Here's Why You Should Retain Chemed (CHE) Stock for Now
|
Apr 16 |
Here's Why You Should Retain Charles River (CRL) Stock Now
|
Apr 16 |
Bio-Rad (BIO) Hurt by Softness in BioPharma and Competition
|
Apr 16 |
Institutional investors in Stryker Corporation (NYSE:SYK) lost 3.0% last week but have reaped the benefits of longer-term growth
|
Apr 12 |
Hologic's (HOLX) New Launches Aid, Macroeconomic Issues Ail
|
Apr 11 |
Smith+Nephew (SNN) Expands in Australia With New Alliance
|
Apr 11 |
Boston Scientific (BSX) Faces Rising Costs, Competition
|
Apr 10 |
Align Technology (ALGN) Up 20.5% YTD: Will the Rally Continue?
|
Apr 10 |
Boston Scientific (BSX) Faces Rising Costs, Competition
|
Apr 9 |
Here's Why You Should Retain Myriad Genetics (MYGN) Stock Now
|